Investor Presentaiton slide image

Investor Presentaiton

Accelerate Life-Saving Treatments ■ With a foundation as the leading, global provider of research models, we have built upon this legacy to develop a diverse portfolio of products and services that spans discovery, non-clinical development, and manufacturing ■ Serve as an indispensable partner to our clients, providing scientific expertise and collaboration to support research at every point along the drug continuum ■ Providing a broad portfolio and global scale allows clients to enhance their productivity and effectiveness, while lowering costs and increasing speed to market ☐ ■ Commit to transforming the drug development process and delivering innovative, safe, and effective treatments to patients faster Innovate scientifically and technologically to achieve our goal of further reducing our clients' drug development timelines Every Moment Matters CRL has worked on >80% of drugs approved by the U.S. Food and Drug Administration (FDA) over the last 5 years 10+ Average number of years to develop a new therapeutic ~$2.5B Average cost to research and develop each successful drug Charles River Laboratories (CRL) 3
View entire presentation